Biotech Startup LambdaVision Uses Space Manufacturing to Develop Artificial Retinas for Blindness Treatment
By
Amy Elkavich
Summary
LambdaVision, a biotech startup, is developing artificial retinas made from hundreds of layers of a light-activated protein called bacteriorhodopsin. The company is leveraging the microgravity environment of space to manufacture these retinas, as gravity-driven forces like sedimentation and buoyancy disrupt the layering process on Earth. The artificial retinas could potentially restore vision to millions suffering from macular degeneration. The company has been conducting experiments on the International Space Station to perfect the manufacturing process.
Source
Twitter / XBiotech Startup LambdaVision Uses Space Manufacturing to Develop Artificial Retinas for Blindness Treatmentissnationallab.orgKey quotes
· 3 pulledLambdaVision CEO Nicole Wagner working with bacteriorhodopsin, the purple protein used to create the company's artificial retinas.
A biotechnology startup is harnessing the unique space environment to manufacture artificial retinas that could one day restore vision to the millions of people blinded by macular degeneration.
On Earth, gravity-driven forces such as sedimentation and buoyancy can cause uneven distribution of the protein layers, compromising the retina's performance.
You might also wanna read
Life Biosciences' ER-100 gene therapy aims to restore vision by rejuvenating retinal neurons through epigenetic reprogramming
Life Biosciences has developed ER-100, a first-ever experimental gene therapy that aims to restore vision by rejuvenating damaged retinal ne
interestingengineering.com·26d ago
Life Biosciences Doses First Patient in FDA-Approved Gene Therapy Trial for Age-Related Blindness
Life Biosciences has dosed its first patient in an FDA-approved clinical trial testing a gene therapy designed to reverse cellular aging. Th
gizmodo.com·22d ago
Researchers Develop Experimental 'Living Eye Drops' Using Engineered Bacteria to Heal Corneas
Researchers are developing experimental "living eye drops" that use genetically engineered bacteria to heal the cornea. The therapy, created
bit.ly·17d ago
Life Biosciences Begins First Human Trial of Cellular Rejuvenation Drug for Age-Related Vision Loss
Life Biosciences has dosed the first human patient with ER-100, a cellular rejuvenation therapy designed to reverse age-related sight loss b
wired.com·18d ago
Biohub Seeks Optical Engineer for Advanced Light Sheet Microscopy in AI-Driven Biomedical Research
Biohub is a 501(c)(3) biomedical research organization building the first large-scale scientific initiative that combines frontier AI models
DARPA's Generative Optogenetics Program Aims to Revolutionize DNA/RNA Synthesis Using Light
DARPA's Generative Optogenetics (GO) program aims to revolutionize DNA and RNA synthesis by using light to direct their creation directly wi
darpa.mil·6mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.